Hypothyroidism after interleukin-2 therapy.
Hartmann
L C
LC
Urba
W J
WJ
Steis
R G
RG
Smith
J W
JW
VanderMolen
L
L
Creekmore
S P
SP
Longo
D L
DL
D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000556:secondary*; D003131:Combined Modality Therapy; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced*; D007376:Interleukin-2 / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000556:secondary*; D008875:Middle Aged
D007376:Interleukin-2